Empagliflozin/Metformin Hydrochloride Tablet 12.5/1000 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
MFDS item code 202302724 · Approved 2023.09.12
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with empagliflozin and metformin for improving blood sugar control in adults with type 2 diabetes, in conjunction with dietary and exercise therapy. It can be administered especially to those with type 2 diabetes who have inadequate blood sugar control and existing cardiovascular diseases; however, safety information related to cardiovascular events should refer to professional clinical trial data. Overall, this drug is used as an effective treatment for improving blood sugar control.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines, such as insulin, the recommended dose of this medicine is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient’s existing metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from concomitant therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin should receive their existing doses of empagliflozin and metformin. When this medicine is administered concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Interactions under Precautions for Use). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If a dose of this medicine is missed, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated using the individual single-ingredient products of empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see section 3. Use with caution in the following patients, item 1, under Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see section 2. Do not administer to the following patients, item 2, under Precautions for Use). Elderly patients In patients 75 years of age and older, renal function and the risk of volume depletion should be considered.
This medication aids in controlling blood sugar and is used for diabetes treatment. Caution is advised as rare side effects such as severe lactic acidosis may occur when taking this medication. Lactic acidosis can cause a serious condition due to the accumulation of lactic acid in the body, which may at times be life-threatening. Furthermore, when taken in conjunction with insulin or sulfonylurea medications, there is a risk of hypoglycemia, so careful monitoring of blood sugar levels is necessary. Patients with reduced kidney function or acute kidney impairment should avoid using this medication due to potential risks. Administration should also be avoided in cases of acute infection, dehydration, severe heart failure, acute myocardial infarction, and other unstable physical conditions. It is recommended not to use this medication in pregnant women or those who may become pregnant, as well as nursing women. This medication may affect body fluid levels, and elderly patients over 75 years of age or those at risk for low blood pressure should use it with caution. Symptoms such as urinary tract infections or genitourinary infections may occur while on this medication; immediate consultation with healthcare professionals is recommended should any symptoms appear. Regular blood tests and kidney function tests should be conducted while using this medication, and periodic checks of vitamin B12 levels are also suggested. Before and after surgery or tests using iodine contrast agents, the use of this medication should be temporarily discontinued until kidney function has returned to normal. In the event of overdose, serious conditions requiring dialysis may arise, hence it is critical to adhere strictly to the prescribed dosage and administration. This medication may interact with other diabetes treatments, so if taking other medications, it is imperative to inform healthcare providers.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture; therefore, it should be stored in a tightly sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. This will help preserve the efficacy and safety of the drug over time.
Bilayer, convex, oval film-coated tablet with a dark brownish-purple color
60 tablets/box [(10 tablets/PTP x 6)], 10 tablets/box [(10 tablets/PTP x 1)], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Myeongmun Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.